ロード中...
Enhancing T cell therapy through TCR signaling-responsive nanoparticle drug delivery
Adoptive cell therapy (ACT) with antigen-specific T cells has shown remarkable clinical success, but approaches to safely and effectively augment T cell function, especially in solid tumors, remain of great interest. Here we describe a strategy to “backpack” large quantities of supporting protein dr...
保存先:
| 出版年: | Nat Biotechnol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078803/ https://ncbi.nlm.nih.gov/pubmed/29985479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4181 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|